Full Text View
Tabular View
No Study Results Posted
Related Studies
Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)
This study has been completed.
Study NCT00006204   Information provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA)

First Received on September 11, 2000.   Last Updated on December 7, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alcoholism
Alcohol Dependence
Depression
Additional conditions recognized in this trial
Depressive Disorder
More general conditions related to this trial
Alcohol-Related Disorders
Behavioral Symptoms
Mental Disorders
Mood Disorders
Substance-Related Disorders
Interventions listed in this trial
naltrexone (Revia)
fluoxetine (Prozac)
Additional drug interventions recognized in this trial
Fluoxetine
Naltrexone
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Narcotic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Institute on Alcohol Abuse and Alcoholism (NIAAA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services